Radionuclide imaging in the post-genomic era

Journal of Cellular Biochemistry

Volumn , Issue SUPPL. 39, 2002, Pages 1-10

  Haberkorn, Uwe ^a   Altmann, Annette ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Functional genomics; Imaging; Nuclear medicine; Radionuclides

Indexed keywords

PROTEOME; TRACER;

ARTICLE; BIOENGINEERING; DRUG DISCRIMINATION; GENE EXPRESSION; GENE FUNCTION; GENE SEQUENCE; GENOME; HUMAN; NONHUMAN; PHARMACOGENOMICS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN STRUCTURE; REPORTER GENE; SCINTISCANNING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; ANIMAL; GENE EXPRESSION REGULATION; GENETIC DISORDER; GENETIC PROCEDURES; GENETICS; GENOMICS; METHODOLOGY; REVIEW;

ANIMALIA;

ANIMALS; GENE EXPRESSION REGULATION; GENETIC DISEASES, INBORN; GENETIC TECHNIQUES; GENOMICS; HUMANS; RADIONUCLIDE IMAGING;

EID: 0036983998     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcb.10386     Document Type: Article

References (53)

1. 18F]-FHPG) in vitro and in vivo as a probe for PET imaging of gene incorporation and expression in tumors. Nucl Med Biol 26:371-376.
2. Anderson NL, Anderson NG. 1998. Proteome and proteomics: New technologies, new concepts, and new words. Electrophoresis 19:1853-1861.
3. Anderson L, Seilhamer J. 1997. A comparison of selected mRNA and protein abundances in human liver. Electrophoresis 18:533-537.
4. Arnold FH. 2001. Combinatorial and computational challenges for biocatalyst design. Nature 409:253-257.
5. Bogdanov A, Simonova M, Weissleder R. 1998. Design of metal-binding green fluorescent protein variants. Biochim Biophys Acta 1397:56-64.
6. Cammilleri S, Sangrajrang S, Perdereau B, Brixy F, Calvo F, Bazin H, Magdelenat H. 1996. Biodistribution of iodine-125 tyramine transforming growth factor? Antisense oligonucleotide in athymic mice with a human mammary tumor xenograft following intratumoral injection. Eur J Nucl Med 23:448-452.
7. Claverie JM. 1999. Computational methods for the identification of differential and coordinated gene expression. Hum Mol Genet 8:1821-1832.
8. Claverie JM. 2001. What if there are only 30,000 human genes? Science 291:1255-1257.
9. 18F]FHPG as PET tracers for herpes simplex virus thymidine kinase enzyme activity and human cytomegalovirus infections. Nucl Med Biol 27:113-119.
10. Dewanjee MK, Ghafouripour AK, Kapadvanjwala M, Dewanjee S, Serafini AN, Lopez DM, Sfakianakis GN. 1994. Noninvasive imaging of c-myc oncogene messenger RNA with indium-111-antisense probes in a mammary tumor-bearing mouse model. J Nucl Med 35:1054-1063.
11. Eisenberg D, Marcotte EM, Xenarios I, Yeates TO. 2000. Protein function in the post-genomic era. Nature 405:823-826.
12. Fred S, Wouters PJ, Verveer P, Bastiaens IH. 2001. Imaging biochemistry inside cells. Trends Cell Biol 11:203-211.
13. Futcher B, Latter GI, Monardo P, McLaughlin CS, Garrels JI. 1999. A sampling of the yeast proteome. Mol Cell Biol 19:7357-7368.
14. Gambhir SS, Barrio JR, Phelps ME, Iyer M, Namavari M, Satyamurthy N, Wu L, Green A, Bauer E, MacLaren DC, Nguyen K, Berk AJ, Cherry SR, Herschman H. 1999. Imaging adenoviral-directed reporter gene expression in living animals with positron emission tomography. Proc Natl Acad Sci USA 96:2333-2338.
15. Gambhir SS, Bauer E, Black ME, Liang Q, Kokoris MS, Barrio JR, Iyer M, Namavari M, Phelps ME, Herschman HR. 2000. A mutant herpes simplex virus type 1 thymidine kinase reporter gene shows improved sensitivity for imaging reporter gene expression with positron emission tomography. Proc Natl Acad Sci USA 97:2785-2790.
16. Gygi SP, Rist B, Gerber SA, Turecek F, Gelb MH, Aebersold R. 1999. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat Biotechnol 17:994-999.
17. Haberkorn U, Altmann A. 2001. Imaging methods in gene therapy of cancer. Current Gene Ther 1:163-182.
18. Haberkorn U, Altmann A, Morr I, Knopf KW, Germann C, Haeckel R, Oberdorfer F, Kaick G van. 1997. Gene therapy with Herpes Simplex Virus thymidine kinase in hepatoma cells: Uptake of specific substrates. J Nucl Med 38:287-294.
19. Haberkorn U, Bellemann ME, Gerlach L, Morr I, Trojan H, Brix G, Altmann A, Doll J, Kaick G van. 1998. Uncoupling of 2-fluoro-2-deoxyglucose transport and phosphorylation in rat hepatoma during gene therapy with HSV thymidine kinase. Gene Ther 5:880-887.
20. Haberkorn U, Henze M, Altmann A, Jiang S, Morr I, Mahmut M, Peschke P, Debus J, Kübler W, Eisenhut M. 2001a. Transfer of the human sodium iodide symporter gene enhances iodide uptake in hepatoma cells. J Nucl Med 42:317-325.
21. Haberkorn U, Altmann A, Kamencic H, Morr I, Henze M, Jiang S, Metz J, Kinscherf R. 2001b. Glucose transport and apoptosis after gene therapy with HSV thymidine kinase. Eur J Nucl Med 28:1690-1696.
22. Haberkorn U, Altmann A, Eisenhut M. 2002. Functional genomics and proteomics - The role of nuclear medicine. Eur J Nuc Med 29:115-132.
23. 18F)FHPG. Eur J Nucl Med 28:5-12.
24. Iversen PL, Zhu S, Meyer A, Zon G. 1992. Cellular uptake and subcellular distribution of phosphorothioate oligonucleotides into cultured cells. Antisense Res Dev 2:211-222.
25. 11C-labeled phosphorothioate oligodeoxynucleotide. Neuroreport 10:2971-2974.
26. Kolkman JA, Stemmer WPC. 2001. Directed evolution of proteins by exon shuffling. Nat Biotechnol 19:423-428.
27. Liang Q, Satyamurthy N, Barrio JR, Toyokuni T, Phelps ME, Gambhir SS, Herschman HR. 2001. Noninvasive and quantitative imaging, in living animals, of a mutant dopamine D2 receptor reporter gene in which ligand binding is uncoupled from signal transduction. Gene Ther 19:1490-1498.
28. Loke SL, Stein CA, Zhang XH, Mori K, Nakanishi M, Subasinghe C, Cohen JS, Neckers LM. 1989. Characterization of oligonucleotide transport into living cells. Proc Natl Acad Sci USA 86:3474-3478.
29. MacLaren DC, Gambhir SS, Satyamurthy N, Barrio JR, Sharfstein S, Toyokuni T, Wu L, Berk AJ, Cherry SR, Phelps ME, Herschman HR. 1999. Repetitive non-invasive imaging of the dopamine D2 receptor as a reporter gene in living animals. Gene Ther 6:785-791.
30. Morin KW, Knaus EE, Wiebe LI, Xia H, McEwan AJ. 2000. Reporter gene imaging: Effects of ganciclovir treatment on nucleoside uptake, hypoxia, and perfusion in a murine gene therapy tumour model that expresses herpes simplex type-1 thymidine kinase. Nucl Med Commun 21:129-137.
31. Mukhopadhyay T, Tainsky M, Cavender AC, Roth JA. 1991. Specific inhibition of K-ras expression and tumorigenicity of lung cancer cells by antisense RNA. Cancer Res 51:1744-1748.
32. Ohkubo N, Mitsuda N, Tamatani M, Yamaguchi A, Lee YD, Ogihara T, Vitek MP, Tohyama M. 2001. Apolipoprotein E4 stimulates cAMP response element-binding protein transcriptional activity through the extracellular signal-regulated kinase pathway. J Biol Chem 276:3046-3053.
33. Ohlstein EH, Ruffolo RR, Elliott JD. 2000. Drug discovery in the next millenium. Annu Rev Pharmacol Toxicol 40:177-191.
34. Oliver FJ, Collins MKL, Lopez-Rivas A. 1997. Overexpression of a heterologous thymidine kinase delays apoptosis induced by factor deprivation and inhibitors of deoxynucleotide metabolism. J Biol Chem 272:10624-10630.
35. Pradet-Balade B, Boulme F, Beug H, Müllner EW, Garcia-Sanz JA. 2001. Translation control: Bridging the gap between genomics and proteomics? Trends Biochem Sci 26:225-229.
36. Raben D, Buchsbaum DJ, Khazaeli MB, Rosenfeld ME, Gillespie GY, Grizzle WE, Liu T, Curiel DT. 1996. Enhancement of radiolabeled antibody binding and tumor localization through adenoviral transduction of the human carcinoembryonic antigen gene. Gene Ther 3:567-580.
37. Ryu DDY, Nam DH. 2000. Recent progress in biomolecular engineering. Biotechnol Prog 16:2-16.
38. Shi N, Boado RJ, Pardridge WM. 2000. Antisense imaging of gene expression in the brain in vivo. Proc Natl Acad Sci USA 97:14709-14714.
39. Simonova M, Weissleder R, Sergeyev N, Vilissova N, Bogdanov A. 1999. Targeting of green fluorescent protein expression to the cell surface. Biochem Biophys Res Commun 62:638-642.
40. Smith CW, Laasmeyer JG, Edeal JB, Woods TL, Jones SJ. 1999. Effects of serum deprivation, insulin, and dexamethasone on polysome percentages in C2C12 myoblasts and differentiating myoblasts. Tissue Cell 31:451-458.
41. Smithgall TE. 1995. SH2 and SH3 domains: Potential targets for anti-cancer drug design. J Pharmacol Toxicol Methods 34:125-132.
42. Stemmer WPC. 1994. Rapid evolution of protein in vitro by DNA shuffling. Nature 370:389-391.
43. Tavitian B, Terrazzino S, Kühnast B, Marzabal S, Stettler O, Dolle F, Deverre JR, Jobert A, Hinnen F, Bendriem B, Crouzel C, Di Giamberardino L. 1998. In vivo imaging of oligonucleotides with positron emission tomography. Nat Med 4:467-471.
44. Tjuvajev JG, Avril N, Oku T, Sasajima T, Miyagawa T, Joshi R, Safer M, Beattie B, DiResta G, Daghighian F, Augensen F, Koutcher J, Zweit J, Humm J, Larson SM, Finn R, Blasberg RG. 1998. Imaging herpes virus thymidine kinase gene transfer and expression by positron emission tomography. Cancer Res 58:4333-4341.
45. Urbain JL, Shore SK, Vekemans MC, Cosenza SC, DeRiel K, Patel GV, Charkes ND, Malmud LS, Reddy EP. 1995. Scintigraphic imaging of oncogenes with antisense probes: Does it make sense? Eur J Nucl Med 22:499-504.
46. Watanabe N, Sawai H, Endo K, Shinozuka K, Ozaki H, Tanada S, Murata H, Sasaki Y. 1999. Labeling of phosphorothioate antisense oligonucleotides with yttrium-90. Nucl Med Biol 26:239-243.
47. Werner T. 1999. Models for prediction and recognition of eukaryotic promoters. Mamm Genome 10:168-175.
48. Woolf TM, Melton DA, Jennings CGB. 1992. Specificity of antisense oligonucleotides in vivo. Proc Natl Acad Sci USA 89:7305-7309.
49. Wouters Fred S, Verveer Peter J, Bastiaens Philippe IH. 2001. Imaging biochemistry inside cells. Trends Cell Biol 11:203-211.
50. Yu Y, Annala AJ, Barrio JR, Toyokuni T, Satyamurthy N, Namavari M, Cherry SR, Phelps ME, Herschman HR, Gambhir SS. 2000. Quantification of target gene expression by imaging reporter gene expression in living animals. Nat Med 6:933-937.
51. Zamecnik PC, Stephenson ML. 1978. Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide. Proc Natl Acad Sci USA 75:280-285.
52. 188Re. J Nucl Med 41:887-895.
53. Zwick MB, Shen J, Scott JK. 1998. Phage-displayed peptide libraries. Curr Opin Biotechnol 9:427-436.